Kunkel Lori Anne bought ORIC
December 8, 2025 · Form 4 insider transaction
Kunkel Lori Anne bought 10,000 shares of ORIC Pharmaceuticals, Inc. at $7.90 per share, a transaction worth $79.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$7.90
Total value
$79.0K
InsiderKunkel Lori Anne
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 9, 2025
Shares owned after84,200
OwnershipDirect
10b5-1 planNo
AmendedNo